Role of mechanical properties of T cells in shaping the immune response

Recent studies in immunology highlight the critical role of mechanical factors in shaping the immune response. Mechanoimmunology, being an emerging interdisciplinary field, concerns the influence of mechanical stimuli on immune cell behavior, in particularly, T lymphocytes. Microenvironment stiffness, mechanical interactions with the extracellular matrix, and changes in membrane tension are able to modulate T cell activation, migration, proliferation, and effector functions. An optimal mechanical environment enhances T cell activity, whereas increased stiffness of the microenvironment and alterations in extracellular matrix properties may reduce their functional capacity. Key molecules such as Piezo 1, integrins, and Yes-associated protein serve as central regulators of mechanotransduction in immune cells. The expanding knowledge on their role in immune interactions suggests a high degree of interconnected modulation, resulting into a system of coordinated responses to mechanical stimuli. Mechanomodulation alters the intracellular environment, acting as a determinant of metabolic profile of T cell populations. Moreover, these studies presume that mechanosensitive signaling pathways may regulate intercellular interactions and adaptive immune responses, offering broad opportunities for modifying immune reactions. Understanding the mechanotransduction mechanisms provides new prospects for the development of novel therapeutic strategies. Mechanical signals may be leveraged to enhance the efficacy of CAR-T cells by optimizing their activation, proliferation, and infiltration into tumor tissue, which is particularly important in treating malignant neoplasms, especially solid tumors, where CAR-T cell therapy faces significant limitations. Mechanoimmunological approaches are also being explored in the context of autoimmune disease treatment. It is hypothesized that mechanosensitive pathways may regulate excessive T cell activation, preventing autoimmune processes and pathological hyperactivation of the immune system. Moreover, development of effective methods for preventing graft-versus-host disease and transplant rejection, as well as strategies for treating chronic infections, remains an important goal. The spectrum of potential pharmacological interventions includes the use of activators and inhibitors of Piezo 1, integrins, and Yes-associated protein. Bioengineering approaches are also being actively developed. One promising direction involves the use of nanomotors for ex vivo T cell activation, which may improve the efficacy of cellular immunotherapy in various diseases. Furthermore, fine-tuning of immune responses via mechanical properties of the cells could provide a precise regulation of immune activity based on the specific characteristics of pathological processes.